作为结直肠癌诊断生物标志物的血衍生外体tRF-3004a
Manli Zhou1, Xiaoqian Yu2, Jing Zhang3
1Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
Scientific reports
|November 27, 2025
概括
血衍生的外体转移RNA衍生的小RNAs (tsRNAs),特别是tRF-3004a,在结肠直肠癌 (CRC) 患者中显示高水平. 这一发现表明tsRNAs可能是早期CRC检测的新型诊断生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物标志物发现发现
背景情况:
- 转移RNA衍生的小RNAs (tsRNAs) 越来越多地被认为是它们在癌症生物学中的调节作用.
- RNAs的诊断潜力,特别是在结直肠癌 (CRC) 中,仍然在很大程度上未被探索.
- 外体,小细胞外囊泡,是体液中非侵入性生物标志物检测的有希望的来源.
研究的目的:
- 研究血衍生的外体tRF-3004a作为结直肠癌 (CRC) 诊断生物标志物的潜力.
- 为了将血衍生的外体tRF-3004a水平与CRC的临床病理特征相关联.
- 评估tRF-3004a在区分CRC患者与健康对照中的诊断性能.
主要方法:
- 从123名CRC患者和79名健康对照 (HC) 收集了血样本.
- 从血中分离出外体,验证,并使用qRT-PCR量化tRF-3004a表达.
- 使用了统计分析,包括千平方测试和ROC曲线分析.
主要成果:
- 与HC患者相比,CRC患者的血衍生外体tRF-3004a水平显著高于CRC患者,并在手术后降低.
- 提升的tRF-3004a表达与淋巴结转移,TNM分期,CEA水平和神经/血管侵入有显著的相关性.
- 对tRF-3004a的ROC分析显示出有希望的诊断效用 (AUC = 0.819),灵敏度为0.691和特异性为0.861.
结论:
- 血衍生的外体tRF-3004a是一种新的,有前途的结直肠癌诊断生物标志物.
- 将tRF-3004a与CEA和CA19-9等现有生物标志物的组合可以提高诊断准确性 (AUC = 0.867).
- 需要进一步的研究来验证这些发现,并探索治疗影响.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Serum Laboratory Studies, Stool Test, Breath Test
730
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
730


